1 Clark, T., Maximin, S., Meier, J., Pokharel, S. & Bhargava, P. Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment. Current problems in diagnostic radiology44, 479-486, doi:10.1067/j.cpradiol.2015.04.004 (2015).
2 Liu, X. et al. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine : international journal of phytotherapy and phytopharmacology62, 152930, doi:10.1016/j.phymed.2019.152930 (2019).
3 McGlynn, K. A., Petrick, J. L. & London, W. T. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clinics in liver disease19, 223-238, doi:10.1016/j.cld.2015.01.001 (2015).
4 Tang, A., Hallouch, O., Chernyak, V., Kamaya, A. & Sirlin, C. B. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdominal radiology (New York)43, 13-25, doi:10.1007/s00261-017-1209-1 (2018).
5 Xu, X. F. et al. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China. JAMA surgery154, 209-217, doi:10.1001/jamasurg.2018.4334 (2019).
6 Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md.)64, 73-84, doi:10.1002/hep.28431 (2016).
7 Khanna, R. & Verma, S. K. Pediatric hepatocellular carcinoma. World journal of gastroenterology24, 3980-3999, doi:10.3748/wjg.v24.i35.3980 (2018).
8 Hung, T. & Chang, H. Y. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA biology7, 582-585, doi:10.4161/rna.7.5.13216 (2010).
9 Wilusz, J. E., Sunwoo, H. & Spector, D. L. Long noncoding RNAs: functional surprises from the RNA world. Genes & development23, 1494-1504, doi:10.1101/gad.1800909 (2009).
10 Quagliata, L. et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology (Baltimore, Md.)59, 911-923, doi:10.1002/hep.26740 (2014).
11 Bhan, A., Soleimani, M. & Mandal, S. S. Long Noncoding RNA and Cancer: A New Paradigm. Cancer research77, 3965-3981, doi:10.1158/0008-5472.Can-16-2634 (2017).
12 Veatch, J. R., McMurray, M. A., Nelson, Z. W. & Gottschling, D. E. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell137, 1247-1258, doi:10.1016/j.cell.2009.04.014 (2009).
13 Puig, S., Ramos-Alonso, L., Romero, A. M. & Martínez-Pastor, M. T. The elemental role of iron in DNA synthesis and repair. Metallomics : integrated biometal science9, 1483-1500, doi:10.1039/c7mt00116a (2017).
14 Oexle, H., Gnaiger, E. & Weiss, G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochimica et biophysica acta1413, 99-107, doi:10.1016/s0005-2728(99)00088-2 (1999).
15 Miyanishi, K., Tanaka, S., Sakamoto, H. & Kato, J. The role of iron in hepatic inflammation and hepatocellular carcinoma. Free radical biology & medicine133, 200-205, doi:10.1016/j.freeradbiomed.2018.07.006 (2019).
16 Huang, C. et al. Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis. American journal of respiratory cell and molecular biology62, 440-453, doi:10.1165/rcmb.2018-0293OC (2020).
17 Fan, X. et al. Integrated analysis of RNA-binding proteins in human colorectal cancer. World journal of surgical oncology18, 222, doi:10.1186/s12957-020-01995-5 (2020).
18 Zhou, T. & Gao, Y. Expression of Concern to: Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. World journal of surgical oncology17, 103, doi:10.1186/s12957-019-1644-2 (2019).
19 Chen, Z. et al. A seven-lncRNA signature for predicting Ewing's sarcoma. PeerJ9, e11599, doi:10.7717/peerj.11599 (2021).
20 Mehta, K. J., Farnaud, S. J. & Sharp, P. A. Iron and liver fibrosis: Mechanistic and clinical aspects. World journal of gastroenterology25, 521-538, doi:10.3748/wjg.v25.i5.521 (2019).
21 Tirnitz-Parker, J. E., Glanfield, A., Olynyk, J. K. & Ramm, G. A. Iron and hepatic carcinogenesis. Critical reviews in oncogenesis18, 391-407, doi:10.1615/critrevoncog.2013007759 (2013).
22 Li, Y. et al. Correlation Analysis Between Preoperative Serum Iron Level and Prognosis as Well as Recurrence of HCC After Radical Resection. Cancer management and research12, 31-41, doi:10.2147/cmar.S227418 (2020).
23 Rostoker, G. & Vaziri, N. D. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution. Hemodialysis international. International Symposium on Home Hemodialysis21 Suppl 1, S68-s77, doi:10.1111/hdi.12557 (2017).
24 Kontoghiorghes, G. J. & Kontoghiorghe, C. N. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells9, doi:10.3390/cells9061456 (2020).
25 Xie, P. & Guo, Y. LINC00205 promotes malignancy in lung cancer by recruiting FUS and stabilizing CSDE1. Bioscience reports40, doi:10.1042/bsr20190701 (2020).
26 Long, X., Li, Q., Zhi, L. J., Li, J. M. & Wang, Z. Y. LINC00205 modulates the expression of EPHX1 through the inhibition of miR-184 in hepatocellular carcinoma as a ceRNA. Journal of cellular physiology235, 3013-3021, doi:10.1002/jcp.29206 (2020).
27 Shahabi, S. et al. LINC00261 Is an Epigenetically Regulated Tumor Suppressor Essential for Activation of the DNA Damage Response. Cancer research79, 3050-3062, doi:10.1158/0008-5472.Can-18-2034 (2019).
28 Zhang, H. F., Li, W. & Han, Y. D. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma. Cancer biomarkers : section A of Disease markers21, 575-582, doi:10.3233/cbm-170471 (2018).
29 Florio, M. et al. Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion. Science (New York, N.Y.)347, 1465-1470, doi:10.1126/science.aaa1975 (2015).
30 Li, L., Lei, Q., Zhang, S., Kong, L. & Qin, B. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis. Oncology reports38, 2607-2618, doi:10.3892/or.2017.5946 (2017).
31 Zhang, Y. et al. Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma. PloS one9, e100854, doi:10.1371/journal.pone.0100854 (2014).
32 Qin, H. & Liu, W. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A. Journal of cellular physiology234, 3526-3537, doi:10.1002/jcp.26906 (2019).
33 Boutros, R., Lobjois, V. & Ducommun, B. CDC25 phosphatases in cancer cells: key players? Good targets? Nature reviews. Cancer7, 495-507, doi:10.1038/nrc2169 (2007).
34 Yang, X. et al. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells. Clinical cancer research : an official journal of the American Association for Cancer Research24, 1629-1643, doi:10.1158/1078-0432.Ccr-17-2242 (2018).
35 Gong, D. et al. Silencing Long Non-coding RNA LINC01224 Inhibits Hepatocellular Carcinoma Progression via MicroRNA-330-5p-Induced Inhibition of CHEK1. Molecular therapy. Nucleic acids19, 482-497, doi:10.1016/j.omtn.2019.10.007 (2020).
36 Sun, Q., Yu, R., Wang, C., Yao, J. & Zhang, L. Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577. Cancer cell international20, 202, doi:10.1186/s12935-020-01287-8 (2020).
37 Troadec, M. B. et al. Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes. Journal of hepatology44, 391-399, doi:10.1016/j.jhep.2005.07.033 (2006).
38 Sun, P. et al. The involvement of iron in chemerin induced cell cycle arrest in human hepatic carcinoma SMMC7721 cells. Metallomics : integrated biometal science10, 838-845, doi:10.1039/c8mt00099a (2018).
39 Masaldan, S. et al. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox biology14, 100-115, doi:10.1016/j.redox.2017.08.015 (2018).
40 Funauchi, Y. et al. Regulation of iron homeostasis by the p53-ISCU pathway. Scientific reports5, 16497, doi:10.1038/srep16497 (2015).
41 Feng, Y. et al. The relationship between iron metabolism, stress hormones, and insulin resistance in gestational diabetes mellitus. Nutrition & diabetes10, 17, doi:10.1038/s41387-020-0122-9 (2020).
42 Singh, A. P. et al. Interdependent Nutrient Availability and Steroid Hormone Signals Facilitate Root Growth Plasticity. Developmental cell46, 59-72.e54, doi:10.1016/j.devcel.2018.06.002 (2018).
43 López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell153, 1194-1217, doi:10.1016/j.cell.2013.05.039 (2013).
44 Sfera, A., Bullock, K., Price, A., Inderias, L. & Osorio, C. Ferrosenescence: The iron age of neurodegeneration? Mechanisms of ageing and development174, 63-75, doi:10.1016/j.mad.2017.11.012 (2018).
45 Nakamura, T., Naguro, I. & Ichijo, H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochimica et biophysica acta. General subjects1863, 1398-1409, doi:10.1016/j.bbagen.2019.06.010 (2019).
46 Zhang, S. et al. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration. Gastroenterology154, 1421-1434, doi:10.1053/j.gastro.2017.12.013 (2018).
47 Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England)26, 139-140, doi:10.1093/bioinformatics/btp616 (2010).
48 Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics : a journal of integrative biology16, 284-287, doi:10.1089/omi.2011.0118 (2012).
49 Fisher, L. D. & Lin, D. Y. Time-dependent covariates in the Cox proportional-hazards regression model. Annual review of public health20, 145-157, doi:10.1146/annurev.publhealth.20.1.145 (1999).
50 Rizvi, A. A. et al. gwasurvivr: an R package for genome-wide survival analysis. Bioinformatics (Oxford, England)35, 1968-1970, doi:10.1093/bioinformatics/bty920 (2019).
51 Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics12, 77, doi:10.1186/1471-2105-12-77 (2011).
52 Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research13, 2498-2504, doi:10.1101/gr.1239303 (2003).
53 Doncheva, N. T., Morris, J. H., Gorodkin, J. & Jensen, L. J. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. Journal of proteome research18, 623-632, doi:10.1021/acs.jproteome.8b00702 (2019).